| 000 | 018090000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025457.0 | ||
| 008 | 061119s2005 ua a f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.12.02.Ph.D.2005.Sh.S. | ||
| 100 | 0 | _aSherif Mohamed Hassan ElKannishy | |
| 245 | 1 | 0 |
_aStudy on novel biochemical atherogenic risk factors in patients with chronic renal failure / _cSherif Mohamed Hassan ElKannishy ; supervised Bahia Yehia Riad , Ekbal Mohamed Abo Hashem , Mervat ElSayed Mohamed |
| 246 | 1 | 5 | _aدراسة عن العوامل البيوكيميائية الجديدة المسببة لتصلب الشرايين فى مرضى الفشل الكلوى المزمن |
| 260 |
_aCairo : _bSherif Mohamed Hassan ElKannishy , _c2005 |
||
| 300 |
_a211P : _bill , diagrs ; _c30cm |
||
| 502 | _aThesis (PH.D.) - Cairo University - Faculty Of Science - Department Of Biochemistry | ||
| 520 | _aThe present study was designed to determine some novel circulating biochemical atherogenic risk factors such as intermediate - density lipoprotein (IDL) , lipoprotein (a) (LP (a)) , malondialdehyde (MDA) , total homocyteine (tHcy) , nitric oxide (NO) metabolites (NO - 2+NO - 3) and endothelin - 1 (ET - 1) in 30 patients with CAD only and 15 patients suffering from CRF combined with CAD | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aChronic renal failure | |
| 653 | 4 | _aNovel biochemical | |
| 653 | 4 | _aPatients | |
| 700 | 0 |
_aBahia Yehia Riad , _esupervisor |
|
| 700 | 0 |
_aEkbal Mohamed Abo Hashem , _esupervisor |
|
| 700 | 0 |
_aMervat ElSayed Mohamed , _esupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aEnas _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c13804 _d13804 |
||